Cell transfer therapy for cancer: past, present, and future.

Cell transfer therapy for cancer: past, present, and future.

Item
http://www.wikidata.org/entity/Q38205228
Cancer immunotherapy: the beginning of the end of cancer?Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture ModelsHuman NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansionProlonged overall survival in gastric cancer patients after adoptive immunotherapyTransgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity.Making Better Chimeric Antigen Receptors for Adoptive T-cell TherapyIL-2 augments the therapeutic efficacy of adoptively transferred B cells which directly kill tumor cells via the CXCR4/CXCL12 and perforin pathways.Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity.Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy
P2860

Cell transfer therapy for cancer: past, present, and future.

Item
http://www.wikidata.org/entity/Q38205228
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cell transfer therapy for cancer: past, present, and future.
@en
type
label
Cell transfer therapy for cancer: past, present, and future.
@en
prefLabel
Cell transfer therapy for cancer: past, present, and future.
@en
P1433
P1476
P2093
P275
P2860
P304
P31
P356
P478
P50
P5008
P577
P5875
P698
P921
P932
P356
P1433
P1476
Cell transfer therapy for cancer: past, present, and future.
@en
P2093
P275
P2860
P304
P31
P356
P478
P50
P5008
P577
P5875
P698
P921
P932